Evidence map›Paper›PMID 40940570›Full record

ArticleEuropean radiology2026

Impact of intraoperative radiotherapy vs postoperative radiotherapy on survival in early-stage breast cancer patients.

Pengfei Yang, Mengxue Wang, Jiaxin Mao, Peipei Cai, Yu Mao, Xue Zhai, Tingting Tang, Longfei Cao, Yuhe Cai, Guojiang Hou and 1 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pengfei Yang *College of Pharmacy, Xinxiang Medical University, Xinxiang, China. 171048@xxmu.edu.cn.ORCID http://orcid.org/0000-0002-7976-0816
Mengxue Wang *College of Pharmacy, Xinxiang Medical University, Xinxiang, China. 2319878193@qq.com.
Jiaxin MaoCollege of Pharmacy, Xinxiang Medical University, Xinxiang, China.
Peipei CaiCollege of Pharmacy, Xinxiang Medical University, Xinxiang, China.
Yu MaoSchool of Basic Medicine, Xinxiang Medical University, Xinxiang, China.
Xue ZhaiThe First Affiliated Hospital, College of First Clinical, Xinxiang Medical University, Xinxiang, China.
Tingting TangCollege of Pharmacy, Xinxiang Medical University, Xinxiang, China.
Longfei CaoCollege of Pharmacy, Xinxiang Medical University, Xinxiang, China.
Yuhe CaiCollege of Pharmacy, Xinxiang Medical University, Xinxiang, China.
Guojiang HouInnovation Scientific Pty Ltd., Mulgrave, NSW, Australia. K.hou@innovationsci.com.au.
Xinghua ZhaoSchool of Basic Medicine, Xinxiang Medical University, Xinxiang, China. zphx1985@163.com.

Funding

Xinxiang Medical University No. XYBSKYZZ201810
6 · The paper itself

Abstract

objectivesIntraoperative radiotherapy (IORT), has been debated regarding its long-term efficacy in breast cancer treatment. This study aimed to compare the differences among IORT, postoperative radiotherapy, and no radiation on long-term survival in early breast cancer patients undergoing breast-conserving surgery (BCS), as well as to investigate factors influencing the efficacy of different radiotherapy modalities. MATERIALS AND

methodsA cohort of 336,785 early-stage low-risk breast cancer women who underwent BCS from 2000 to 2019 was selected from the Surveillance, Epidemiology, and End Results database, with 2730 in the IORT group, 259,311 in the postoperative radiotherapy group, and 74,744 in the no radiation group. Propensity score matching balanced baseline characteristics. Kaplan-Meier method and landmark analysis were employed to calculate OS, while Cox proportional hazards regression analysis was conducted to identify risk factors for OS. Subgroup analyses explored factors impacting the efficacy of different radiotherapy modalities.

resultsIn short-term survival within 48 months, IORT showed a more favorable prognosis than postoperative radiotherapy (p = 0.028); while there was no significant difference in prognosis between IORT and postoperative radiotherapy (p = 0.318), when beyond 48 months. The prognosis of the no radiation group was poorest. For patients under 50-years-old and hormone receptor-negative subtypes, radiotherapy did not significantly impact prognosis (p > 0.05).

conclusionBreast cancer patients undergoing BCS significantly benefit from radiotherapy. Neither short-term nor long-term survival of IORT is inferior to postoperative radiotherapy, suggesting that IORT can be an effective alternative for early-stage breast cancer patients unsuitable for or unable to undergo postoperative radiotherapy. KEY POINTS: Question As a relatively new radiotherapy approach, the long-term efficacy of IORT compared to postoperative radiotherapy and no radiotherapy remains controversial. Findings IORT may be superior to postoperative radiotherapy in short-term survival of 48 months, and is not inferior to postoperative radiotherapy in long-term survival. Clinical relevance This research hopes to contribute to the further exploration of IORT and offer improved treatment alternatives in early-stage breast cancer patients, particularly those who cannot undergo or face challenges with postoperative radiotherapy.

Indexed as

Breast NeoplasmsIntraoperative CareAdultAgedFemaleHumansMastectomy, SegmentalMiddle AgedNeoplasm StagingPropensity ScoreRadiotherapy, AdjuvantRetrospective StudiesSEER ProgramTreatment OutcomeAdjuvantBreast neoplasmsMastectomyRadiotherapySegmental

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.